The fixed evolution of latest COVID-19 variants makes it essential for clinicians to have a number of therapies of their arsenal for treating drug-resistant infections. Researchers have now found {that a} new class of oral medication that acts straight on human cells can inhibit a various vary of pathogenic SARS-CoV-2 strains.